Clinical trial
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast…
NCT00437359 · Japan Breast Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00437359 |
|---|---|
| Title | Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer |
| Official title | Antiestrogen vs Aromatase Inhibitor After Chemotherapy for Adjuvant Setting: Efficacy of Endocrine Therapy After Chemotherapy in Postoperative Adjuvant Therapy for Breast Cancer |
| Lead sponsor | Japan Breast Cancer Research Network, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Toremifene citrate, Anastrozole |
| Enrollment | 240 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2017 |
| Completion | May 1, 2020 |
| First posted | Feb 21, 2007 |
| Last update posted | Mar 30, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: